Melhores Leucemia médicos em Israel - TOP-20 médicos

Especialista líder em leucemia no Sourasky Medical Center (Ichilov) – o maior e mais avançado hospital de Israel.

• Mais de 25 anos de experiência em hematologia e oncologia
• Especialização realizada num prestigiado centro internacional em Nova Iorque
• Focar-se nos tratamentos médicos mais recentes para a leucemia
• Tratar um elevado volume de casos complexos de cancro do sangue

O Dr. Ram realizou centenas de transplantes de células-tronco, um tratamento fundamental para a leucemia, no Sourasky Medical Center.

• Certificação em Hematologia, Oncologia Médica e Medicina Interna
• Redação de mais de 30 artigos científicos e de um capítulo de livro médico
• Especialização (Fellowship) em Hematologia e Oncologia no Westchester Medical Center
• Conclusão da residência na State University of New York em Brooklyn

Chefe de Onco-hematologia Pediátrica no Hospital Infantil Dana Dwek – A Dra. El Hasid é especialista em transplantes de medula óssea e sangue do cordão umbilical para crianças.

• Realizar mais de 300 procedimentos de transplante
• Publicar mais de 50 artigos de pesquisa e 40 relatórios médicos
• Formar-se no Hospital City of Hope, em Los Angeles
• Ser membro da American Hematology Association

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

O Dr. Shapira é um especialista sénior em transplante de medula óssea no prestigiado Sourasky Medical Center em Tel Aviv.

• Licenciar-se na Faculdade de Medicina da Universidade Hebraica em 1999
• Concluir a formação especializada em medicina interna no Hadassah Medical Center
• Atuar como médico sénior no departamento de Transplante de Medula Óssea do Hadassah
• Falar fluentemente inglês e hebraico para pacientes internacionais

Chefe do Instituto de Hemato-Oncologia do Ichilov Medical Center – O Professor Aviv é especialista em leucemias e especialista em transplante de medula óssea.

• 31 anos de experiência em onco-hematologia
• Liderar o Departamento de Transplante de Medula Óssea
• Médico sênior no Ichilov desde 2003
• Especialista reconhecido em linfomas e leucemias

Chefia o departamento de hematologia e oncologia pediátrica no Centro Médico Sourasky, um importante centro para o tratamento de leucemia infantil em Israel.

• Mais de uma década de experiência com especialização em cancros do sangue pediátricos
• Especialização (Fellowship) em hematologia e oncologia pediátrica no Schneider Children's Medical Center
• Formação especializada no estrangeiro em oncologia óssea e de tecidos moles na Itália
• Coordenar o tratamento de sarcomas para crianças, combinando oncologia pediátrica com ortopedia
• Membro da Sociedade Israelense de Hematologia e Oncologia Pediátrica

A pesquisa e o tratamento do Dr. Herishanu centram-se na leucemia linfocítica crónica, a leucemia mais comum em adultos. Recebeu mais de dez prémios nacionais e internacionais pelo seu trabalho nesta área.

• Hematologista sénior no Sourasky Medical Center de Tel Aviv
• Membro profissional das Associações de Hematologia de Israel e Americana
• Residência em hematologia concluída no Tel Aviv Medical Center
• Publicação extensiva sobre o tratamento e a investigação da LLC

Listado entre os melhores médicos de Israel pela Forbes, o Dr. Gal Goldstein lidera o Departamento de Oncologia e Hemato-Oncologia Pediátrica do Hadassah Medical Center.

• Mais de 20 anos de especialização em hemato-oncologia pediátrica
• Especialista em transplante haploidêntico de medula óssea
• Foco em retinoblastoma e medicina de precisão
• Membro de quatro associações internacionais de oncologia pediátrica
• Formado pela Universidade de Tel Aviv

A Professora Zila Zuckerman é uma dedicada especialista em hematologia e transplantologia no Rambam Medical Center.

• Especialista em cancros do sangue em adultos e crianças
• Focada em transplante de medula óssea para leucemia
• Membro da equipa de um importante centro médico académico

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

A Dra. Stepensky realizou mais de 3.500 transplantes de medula óssea e foi reconhecida pela Forbes como uma das melhores médicas.

• Especializar-se no tratamento de crianças com leucemia e cancros do sangue raros
• 20 anos de prática dedicada em hematologia pediátrica
• Doentes e pais chamam-lhe a médica que «transplanta a vida»

O Dr. Spielberg é um onco-hematologista especializado em cancros do sangue no Assuta Medical Center.

• Especialização focada especificamente em leucemia e outros distúrbios sanguíneos
• Sediado no proeminente hospital privado de Israel, o Assuta Medical Center
• Prestar cuidados integrados de oncologia com acesso a diagnósticos avançados

Chefia o Departamento de Hematologia do Hadassah Medical Center, onde se especializa em tratamentos avançados para cancros do sangue.

• Professora com mais de três décadas de experiência em doenças malignas do sangue
• Formada durante três anos no Memorial Sloan-Kettering Cancer Center, em Nova Iorque
• Especialista em transplante de medula óssea e novas terapias génicas
• Primeira mulher a exercer o cargo de Diretora da Faculdade de Medicina de Hadassah
• Recebeu o prémio Healing with the Heart pelo cuidado excecional ao paciente

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.